FindTrial
Sign In

Vitamin D and type 2 diabetes.

Vitamin D and type 2 diabetes.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2008-003954-13-DK
Enrollment
Unknown
Registered
2008-08-28
Start date
2008-09-30
Completion date
Unknown
Last updated
2012-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus and vitamin D insufficiency/deficiency.

Interventions

Trade Name: Vitamin D3 Product Name: Vitamin D3 Pharmaceutical Form: Tablet INN or Proposed INN: Cholecalciferol Concentration type: equal Pharmaceutical form of the placebo: Tablet Route of administr

Sponsors

Silkeborg Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Written consent Type 2 diabetes Danish extraction Vitamin D insufficiency (Vitamin D 18 år Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Nephropathy (Carbamid > 12 mmol/l) HbA1c 2,52 mmol/l Primæry hyperparathyreoidism serious disease Malabsorption Sarcoidosis Pregnancy

Design outcomes

Primary

MeasureTime frame
Main Objective: To assess the effect of vitamin D supplementation on insulinsensitivity and insulinsecretion in patients with type 2 diabetes and vitamin D insufficiency/deficiency.;Secondary Objective: To assess the effect of vitamin D on glycemic control, lipid status and inflammatory markers in patients with type 2 diabetes and vitamin D insufficiency/deficiency.;Primary end point(s): Insulinsecretion and insulinsensitivity—

Countries

Denmark

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026